COMP <GO>
ROMA vs TBI // ENTERPRISE SCALE & MARKET CAP
Roma Green Finance Limited (Class A) (NASDAQ) VS. TrueBlue Inc. (NYSE) • 15-METRIC TALLY: ROMA 2
— TBI 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ROMA
LAST: $6.54 (+1.71%) • MKT CAP: $383.0M
market-cap
$383.0M
LAST: $9.87 (+1.02%) • MKT CAP: $297.4M
market-cap
$297.4M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ROMA VS. TBI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ROMA | TBI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 17.10% | 22.80% | -5.70 | TBI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -11.70% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.65% | -24.81% | +24.16 | ROMA | /fcf-yield <GO> |
| Operating Margin | -60.00% | -2.90% | -57.10 | TBI | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -3.00% | -57.00 | TBI | /net-margins <GO> |
| Revenue Growth (YoY) | -22.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.73 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | TBI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.1 | 60.8 | -19.70 | TBI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $383.0M | $297.4M | $85.6M | ROMA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ROMA REV | TBI REV | ROMA GROSS % | TBI GROSS % | ROMA FCF | TBI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.2M | $1.62B | 17.1% | 22.8% | -$2.5M | -$73.7M |
| FY 2024 | $1.6M | $1.57B | 37.0% | 25.9% | -$1.6M | -$41.2M |
| FY 2023 | $1.3M | $66.8M | — | — | -$3.2M | $34.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ROMA // BETA —
TBI // BETA —